LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Results

Lemaitre Vascular Beats on EPS, Stock Down 0.78%

Lemaitre Vascular's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.78%, likely due to the absence of revenue figures and forward guidance. Investors may be concerned about the lack of clarity on future performance amidst market challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.62	N/A	+8.20%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed cautious optimism about the company's performance despite market challenges. They emphasized the importance of innovation and product development.

Management highlighted strong performance in key product lines.

They acknowledged challenges in the broader market environment.

Focus remains on innovation and expanding market reach.

Lemaitre Vascular Beats on EPS, Stock Down 0.78%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Beats on EPS, Stock Down 0.78%

Key numbers

Management commentary